Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT
Release Date: 08/17/2026
Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs TRANSCRIPT
Empowered Patient Podcast
Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...
info_outline
Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs
Empowered Patient Podcast
Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...
info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI TRANSCRIPT
Empowered Patient Podcast
Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...
info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI
Empowered Patient Podcast
Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...
info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health TRANSCRIPT
Empowered Patient Podcast
Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits. The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...
info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health
Empowered Patient Podcast
Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits. The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...
info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT
Empowered Patient Podcast
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...
info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran
Empowered Patient Podcast
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...
info_outline
Using AI to Unify Healthcare HR Systems to Reduce Administrative Burden with Craig Ahrens Worki TRANSCRIPT
Empowered Patient Podcast
Craig Ahrens is the CEO of Worki, a healthcare workforce management platform that aggregates fragmented HR records by unifying disparate data sources and deploying AI agents to streamline workflows. To address anxieties, the focus needs to be on reducing administrative burdens through intelligent scheduling, not on eliminating jobs. Transparency is key for employees in this integration of legacy systems with AI-powered tools, so that healthcare organizations can improve resource allocation, enhance retention, and improve patient care while maintaining human oversight. ...
info_outline
Using AI to Unify Healthcare HR Systems to Reduce Administrative Burden with Craig Ahrens Worki
Empowered Patient Podcast
Craig Ahrens is the CEO of Worki, a healthcare workforce management platform that aggregates fragmented HR records by unifying disparate data sources and deploying AI agents to streamline workflows. To address anxieties, the focus needs to be on reducing administrative burdens through intelligent scheduling, not on eliminating jobs. Transparency is key for employees in this integration of legacy systems with AI-powered tools, so that healthcare organizations can improve resource allocation, enhance retention, and improve patient care while maintaining human oversight. ...
info_outlineSharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations.
Sharon explains, "So RxTran’s mission is to provide certified translation of the dosing instructions on prescription labels and ensure that LEP patients have the ability to understand their dosing instructions. And our primary clients include both small individual pharmacies as well as large chains."
"Truthfully, everybody needs the exact same standard of care, whether you are proficient in English or not. And we always say that good enough is not good enough. So it is our belief that you absolutely must have the translated SIGS be done by a pharmacist who is native in the language into which it's being translated. And then be stored in a bank. So it's not pre-written text dosing instructions. It is from a data bank of certified translations."
"So, right now, there are sort of three real issues in that situation. And the dangerous outcomes include the patient won't take the medication because they're fearful. Or they take the wrong dose or at the wrong time. And what we hear time and time again is that they rely on an untrained relative, neighbor, or friend to translate. And all of these just really potentially cause great harm."
#RxTran #PatientSafety #HealthEquity #Pharmacy #LimitedEnglishProficiency #LEPpatients #MedicationSafety #LanguageAccess #HealthcareInnovation #PatientAdvocacy #HealthcareInnovation #EmpoweredPatient #MedicationAdherence #PharmacyInnovation #WomenInHealthTech #HealthTech
